Longevity
Epitalon
Epithalon, Ala-Glu-Asp-Gly
Epitalon is a synthetic four-amino-acid peptide modeled on epithalamin, an extract from the pineal gland. It is popular in longevity circles, but it is not FDA-approved and its human evidence is thin.
Key facts
- Commonly discussed for: healthy aging, sleep and telomere support.
- Evidence (D): Most data are cell and animal studies (for example telomere work in human cell lines). Human reports come largely from one Russian research group, and the best known, a 266-person elderly cohort, used the epithalamin extract rather than synthetic Epitalon.
- FDA status: PCAC recommended. On July 24, 2026 the PCAC voted 7-4 (1 abstention) to recommend Epitalon for the 503A Bulks List for insomnia. In a notice published Oct 30, 2026, HHS said it does not intend to take enforcement action against licensed pharmacies and physicians compounding it under set conditions while the FDA writes rules. That is interim enforcement discretion, not FDA approval, and the FDA had not proposed adding it to the list as of Nov 18, 2026.
- Legitimate access: Prescription compounding under an interim HHS policy (not FDA-approved).
- Last reviewed: October 1, 2026.
Read the deep dives
Sources
- Epitalon increases telomere length in human cell lines. Biogerontology, 2025
- Khavinson & Morozov. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett, 2003
- McDermott Will & Schulte: PCAC backs majority of peptides in two-day public meeting (July 2026)
- Federal Register notice of PCAC meeting and uses under review (April 16, 2026)